R&D Costs: It's Industry's Problem
If high prices that lower access are attributable to a flawed R&D model, can industry embrace delivering better results at lower costs.
Fostering a Legacy of Leadership
Pharm Exec's 2011 Emerging Leaders celebration convened Oct. 6 in New York.
The Rx Club's 25th Anniversary Show
Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?
Invitation Application for Pharma and Biotech Industry Executives:
UPS Survey Unveils Healthcare Supply Chain Trends
Pharmaceutical Executive Digital Edition - October 2011
Thirty Years of Pharm Exec
Atsushi Nagahisa: Creating Customer Value
Atsushi Nagahisa, President & CEO, RaQualia
Physicians: Still the Vital Connection in Medicine
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
IP: Securing a Global Consensus—Can Industry Do It Again?
Harvey Bale, Jr., MD, former Director-General, IFPMA
In Establishing the Evidence Base, He Made Science Count
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
Jane Henney: Lessons from the FDA Front Line
Jane Henney, MD, Former FDA Commissioner
P. Roy Vagelos: Getting to No. 1—and Staying There
P. Roy Vagelos, MD, Chairman Emeritus, Merck
Francis Collins: Guiding a Revolution in Science
Francis Collins, MD, PhD, Director, National Institutes of Health
Napoleone Ferrara: Curative Powers of Collaboration
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
Martin Wygod: Arming up for the Digital Revolution
Martin Wygod, Chairman, WebMD
Sidney Wolfe: Pharma's Unlikely Best Friend
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
Peter Piot: The Crisis Manager
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine
Sir Martin Sorrell: Teamwork and Trust
Sir Martin Sorrell, CEO, WPP
Fernand Sauer: The Essential—and Effective—Bureaucrat
Fernand Sauer, First Director General, European Medicines Agency
Productivity, Reputation are Keys to Global Leadership
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
Romania: Staking its Claim
Increasing intergration with the world economy and accession to the Europen Union have been key pillars in talking the growth potential of Romania's pharmaceutical market to greater heights.
Partnering with the New Players
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation
Three Decades of Politics and Pop Culture ... on Drugs
Pharmaceutical Executive Digital Edition - September 2011
From Many, One
Innovating Around Innovation
Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
Two Million Man Hours
PricewaterhouseCooper's "Global Construction 2020" report predictions
Get Back in the Box!
Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.
Pharmaceutical Executive Digital Edition - August 2011
Carrying the Weight of the Future
Giving Press Releases New Legs
Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed
Europe in HTA Gridlock
HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.
